Cross‐sectional and longitudinal evaluation of plasma glial fibrillary acidic protein to detect and predict clinical syndromes of Alzheimer's disease

Abstract Introduction This study examined plasma glial fibrillary acidic protein (GFAP) as a biomarker of cognitive impairment due to Alzheimer's disease (AD) with and against plasma neurofilament light chain (NfL), and phosphorylated tau (p‐tau)181+231. Methods Plasma samples were analyzed using Si...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Madeline Ally, Michael A. Sugarman, Henrik Zetterberg, Kaj Blennow, Nicholas J. Ashton, Thomas K. Karikari, Hugo J. Aparicio, Brandon Frank, Yorghos Tripodis, Brett Martin, Joseph N. Palmisano, Eric G. Steinberg, Irene Simkin, Lindsay A. Farrer, Gyungah R. Jun, Katherine W. Turk, Andrew E. Budson, Maureen K. O'Connor, Rhoda Au, Lee E. Goldstein, Neil W. Kowall, Ronald Killiany, Robert A. Stern, Thor D. Stein, Ann C. McKee, Wei Qiao Qiu, Jesse Mez, Michael L. Alosco
Format:	Artigo
Sprog:	Inglês
Udgivet:	Wiley 2023-10-01
Serier:	Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Fag:	Alzheimer's disease glial fibrillary acidic protein neuropsychology neurofilament light chain phosphorylated tau plasma biomarkers
Online adgang:	https://doi.org/10.1002/dad2.12492
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!